Frequency of the use of vagus nerve stimulation for the treatment of intractable epilepsy during the first year of public health insurance coverage with in Kyushu Rosai Hospital and other areas in Japan

Takato Morioka, Tetsuro Sayama, Takafumi Shimogawa, Takeshi Hamamura, Kimiaki Hashiguchi, Kensuke Kawai, Nobutaka Mukae, Nobuya Murakami, Tomio Sasaki

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

抄録

Vagus nerve Stimulation (VNS) is a palliative treatment for medically intractable epilepsy and has been covered by public health insurance in Japan since July 1, 2010. The frequency of the use of VNS during the first year of insurance coverage was determined by assessing the number of cases for which VNS was performed in Kyushu Rosai Hospital, the number of registered cases, and the questionnaire survey filled by 68 surgeons who are board certified as both epileptologists and neurosurgeons. VNS devices were placed in 98 patients from July 2010 to June 2011. These devices were placed in an average of 4.4 patients per month from July 2010 to November 2010 and in an average of 10.9 patients from December 2010 to June 2011. However, we did not observe an increasing trend. Almost all of the surgeries were performed in the Kanto (56 patients in 8 institutes) and Tokai (24 patients in 2 institutes) areas. VNS was not performed in many institutes primarily because VNS was not indicated for any of the patients. The questionnaire survey indicated that the use of VNS was likely to increase with an increase in the number of neurologists who decide on performing VNS preoperatively and regulate the conditions of the vagus nerve stimulator postoperatively. In conclusion, VNS is currently being applied in a limited number of institutes in the Kanto and Tokai areas, and a close association between the epileptologists and neurologists during preoperative and postoperative periods will increase the use of VNS.

元の言語英語
ページ(範囲)681-687
ページ数7
ジャーナルBrain and Nerve
64
発行部数6
出版物ステータス出版済み - 6 1 2012

Fingerprint

Vagus Nerve Stimulation
Insurance Coverage
Health Insurance
Japan
Public Health
Therapeutics
Drug Resistant Epilepsy
Preoperative Period
Equipment and Supplies
Vagus Nerve
Palliative Care
Postoperative Period

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

これを引用

Frequency of the use of vagus nerve stimulation for the treatment of intractable epilepsy during the first year of public health insurance coverage with in Kyushu Rosai Hospital and other areas in Japan. / Morioka, Takato; Sayama, Tetsuro; Shimogawa, Takafumi; Hamamura, Takeshi; Hashiguchi, Kimiaki; Kawai, Kensuke; Mukae, Nobutaka; Murakami, Nobuya; Sasaki, Tomio.

:: Brain and Nerve, 巻 64, 番号 6, 01.06.2012, p. 681-687.

研究成果: ジャーナルへの寄稿記事

Morioka, Takato ; Sayama, Tetsuro ; Shimogawa, Takafumi ; Hamamura, Takeshi ; Hashiguchi, Kimiaki ; Kawai, Kensuke ; Mukae, Nobutaka ; Murakami, Nobuya ; Sasaki, Tomio. / Frequency of the use of vagus nerve stimulation for the treatment of intractable epilepsy during the first year of public health insurance coverage with in Kyushu Rosai Hospital and other areas in Japan. :: Brain and Nerve. 2012 ; 巻 64, 番号 6. pp. 681-687.
@article{f4ad85b86edd40dcac1e60a8e7d04cc8,
title = "Frequency of the use of vagus nerve stimulation for the treatment of intractable epilepsy during the first year of public health insurance coverage with in Kyushu Rosai Hospital and other areas in Japan",
abstract = "Vagus nerve Stimulation (VNS) is a palliative treatment for medically intractable epilepsy and has been covered by public health insurance in Japan since July 1, 2010. The frequency of the use of VNS during the first year of insurance coverage was determined by assessing the number of cases for which VNS was performed in Kyushu Rosai Hospital, the number of registered cases, and the questionnaire survey filled by 68 surgeons who are board certified as both epileptologists and neurosurgeons. VNS devices were placed in 98 patients from July 2010 to June 2011. These devices were placed in an average of 4.4 patients per month from July 2010 to November 2010 and in an average of 10.9 patients from December 2010 to June 2011. However, we did not observe an increasing trend. Almost all of the surgeries were performed in the Kanto (56 patients in 8 institutes) and Tokai (24 patients in 2 institutes) areas. VNS was not performed in many institutes primarily because VNS was not indicated for any of the patients. The questionnaire survey indicated that the use of VNS was likely to increase with an increase in the number of neurologists who decide on performing VNS preoperatively and regulate the conditions of the vagus nerve stimulator postoperatively. In conclusion, VNS is currently being applied in a limited number of institutes in the Kanto and Tokai areas, and a close association between the epileptologists and neurologists during preoperative and postoperative periods will increase the use of VNS.",
author = "Takato Morioka and Tetsuro Sayama and Takafumi Shimogawa and Takeshi Hamamura and Kimiaki Hashiguchi and Kensuke Kawai and Nobutaka Mukae and Nobuya Murakami and Tomio Sasaki",
year = "2012",
month = "6",
day = "1",
language = "English",
volume = "64",
pages = "681--687",
journal = "Brain and Nerve",
issn = "1881-6096",
publisher = "Igaku-Shoin Ltd",
number = "6",

}

TY - JOUR

T1 - Frequency of the use of vagus nerve stimulation for the treatment of intractable epilepsy during the first year of public health insurance coverage with in Kyushu Rosai Hospital and other areas in Japan

AU - Morioka, Takato

AU - Sayama, Tetsuro

AU - Shimogawa, Takafumi

AU - Hamamura, Takeshi

AU - Hashiguchi, Kimiaki

AU - Kawai, Kensuke

AU - Mukae, Nobutaka

AU - Murakami, Nobuya

AU - Sasaki, Tomio

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Vagus nerve Stimulation (VNS) is a palliative treatment for medically intractable epilepsy and has been covered by public health insurance in Japan since July 1, 2010. The frequency of the use of VNS during the first year of insurance coverage was determined by assessing the number of cases for which VNS was performed in Kyushu Rosai Hospital, the number of registered cases, and the questionnaire survey filled by 68 surgeons who are board certified as both epileptologists and neurosurgeons. VNS devices were placed in 98 patients from July 2010 to June 2011. These devices were placed in an average of 4.4 patients per month from July 2010 to November 2010 and in an average of 10.9 patients from December 2010 to June 2011. However, we did not observe an increasing trend. Almost all of the surgeries were performed in the Kanto (56 patients in 8 institutes) and Tokai (24 patients in 2 institutes) areas. VNS was not performed in many institutes primarily because VNS was not indicated for any of the patients. The questionnaire survey indicated that the use of VNS was likely to increase with an increase in the number of neurologists who decide on performing VNS preoperatively and regulate the conditions of the vagus nerve stimulator postoperatively. In conclusion, VNS is currently being applied in a limited number of institutes in the Kanto and Tokai areas, and a close association between the epileptologists and neurologists during preoperative and postoperative periods will increase the use of VNS.

AB - Vagus nerve Stimulation (VNS) is a palliative treatment for medically intractable epilepsy and has been covered by public health insurance in Japan since July 1, 2010. The frequency of the use of VNS during the first year of insurance coverage was determined by assessing the number of cases for which VNS was performed in Kyushu Rosai Hospital, the number of registered cases, and the questionnaire survey filled by 68 surgeons who are board certified as both epileptologists and neurosurgeons. VNS devices were placed in 98 patients from July 2010 to June 2011. These devices were placed in an average of 4.4 patients per month from July 2010 to November 2010 and in an average of 10.9 patients from December 2010 to June 2011. However, we did not observe an increasing trend. Almost all of the surgeries were performed in the Kanto (56 patients in 8 institutes) and Tokai (24 patients in 2 institutes) areas. VNS was not performed in many institutes primarily because VNS was not indicated for any of the patients. The questionnaire survey indicated that the use of VNS was likely to increase with an increase in the number of neurologists who decide on performing VNS preoperatively and regulate the conditions of the vagus nerve stimulator postoperatively. In conclusion, VNS is currently being applied in a limited number of institutes in the Kanto and Tokai areas, and a close association between the epileptologists and neurologists during preoperative and postoperative periods will increase the use of VNS.

UR - http://www.scopus.com/inward/record.url?scp=84862576209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862576209&partnerID=8YFLogxK

M3 - Article

C2 - 22647476

AN - SCOPUS:84862576209

VL - 64

SP - 681

EP - 687

JO - Brain and Nerve

JF - Brain and Nerve

SN - 1881-6096

IS - 6

ER -